{
    "organizations": [],
    "uuid": "17910316e2d275e74096ab703c5a333e13fcf0a0",
    "author": "",
    "url": "https://www.reuters.com/article/brief-cipla-ties-up-with-roche-to-sell-t/brief-cipla-ties-up-with-roche-to-sell-tocilizumab-bevacizumab-in-india-idUSL4N1QH5IX",
    "ord_in_thread": 0,
    "title": "BRIEF-Cipla ties up with Roche to sell tocilizumab, bevacizumab in India",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "February 27, 2018 / 2:04 PM / Updated 13 minutes ago BRIEF-Cipla ties up with Roche to sell tocilizumab, bevacizumab in India Reuters Staff 1 Min Read Feb 27 (Reuters) - Cipla Ltd: * Cipla says signed deal with Roche Pharma India to promote, sell tocilizumab and the second brand of Roche's Avastin in India Source text for Eikon: ( bit.ly/2CmX0t5 ) Further company coverage: (Reporting By Zeba Siddiqui)",
    "published": "2018-02-27T16:04:00.000+02:00",
    "crawled": "2018-02-27T16:23:17.020+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "february",
        "pm",
        "updated",
        "minute",
        "ago",
        "tie",
        "roche",
        "sell",
        "tocilizumab",
        "bevacizumab",
        "india",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "cipla",
        "ltd",
        "cipla",
        "say",
        "signed",
        "deal",
        "roche",
        "pharma",
        "india",
        "promote",
        "sell",
        "tocilizumab",
        "second",
        "brand",
        "roche",
        "avastin",
        "india",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "reporting",
        "zeba",
        "siddiqui"
    ]
}